Mendelian susceptibility to mycobacterial disease: 2014–2018 update

Jérémie Rosain, Xiao Fei Kong, Ruben Martinez-Barricarte, Carmen Oleaga-Quintas, Noé Ramirez-Alejo, Janet Markle, Satoshi Okada, Stéphanie Boisson-Dupuis, Jean Laurent Casanova, Jacinta Bustamante

Research output: Contribution to journalArticle

Abstract

Mendelian susceptibility to mycobacterial disease (MSMD) is caused by inborn errors of IFN-γ immunity. Since 1996, disease-causing mutations have been found in 11 genes, which, through allelic heterogeneity, underlie 21 different genetic disorders. We briefly review here progress in the study of molecular, cellular and clinical aspects of MSMD since the last comprehensive review published in 2014. Highlights include the discoveries of (1) a new genetic etiology, autosomal recessive signal peptide peptidase-like 2 A deficiency, (2) TYK2-deficient patients with a clinical phenotype of MSMD, (3) an allelic form of partial recessive IFN-γR2 deficiency, and (4) two forms of syndromic MSMD: RORγ/RORγT and JAK1 deficiencies. These recent findings illustrate how genetic and immunological studies of MSMD can shed a unique light onto the mechanisms of protective immunity to mycobacteria in humans.

Original languageEnglish (US)
JournalImmunology and Cell Biology
DOIs
StateAccepted/In press - Jan 1 2018

Fingerprint

Immunity
Inborn Genetic Diseases
Mycobacterium
Phenotype
Light
Mutation
Genes
signal peptide peptidase
Tyrosine Kinase 2 Deficiency

Keywords

  • IFN-γ
  • mycobacterium
  • next-generation sequencing
  • primary immunodeficiency

ASJC Scopus subject areas

  • Immunology and Allergy
  • Immunology
  • Cell Biology

Cite this

Rosain, J., Kong, X. F., Martinez-Barricarte, R., Oleaga-Quintas, C., Ramirez-Alejo, N., Markle, J., ... Bustamante, J. (Accepted/In press). Mendelian susceptibility to mycobacterial disease: 2014–2018 update. Immunology and Cell Biology. https://doi.org/10.1111/imcb.12210

Mendelian susceptibility to mycobacterial disease : 2014–2018 update. / Rosain, Jérémie; Kong, Xiao Fei; Martinez-Barricarte, Ruben; Oleaga-Quintas, Carmen; Ramirez-Alejo, Noé; Markle, Janet; Okada, Satoshi; Boisson-Dupuis, Stéphanie; Casanova, Jean Laurent; Bustamante, Jacinta.

In: Immunology and Cell Biology, 01.01.2018.

Research output: Contribution to journalArticle

Rosain, J, Kong, XF, Martinez-Barricarte, R, Oleaga-Quintas, C, Ramirez-Alejo, N, Markle, J, Okada, S, Boisson-Dupuis, S, Casanova, JL & Bustamante, J 2018, 'Mendelian susceptibility to mycobacterial disease: 2014–2018 update', Immunology and Cell Biology. https://doi.org/10.1111/imcb.12210
Rosain J, Kong XF, Martinez-Barricarte R, Oleaga-Quintas C, Ramirez-Alejo N, Markle J et al. Mendelian susceptibility to mycobacterial disease: 2014–2018 update. Immunology and Cell Biology. 2018 Jan 1. https://doi.org/10.1111/imcb.12210
Rosain, Jérémie ; Kong, Xiao Fei ; Martinez-Barricarte, Ruben ; Oleaga-Quintas, Carmen ; Ramirez-Alejo, Noé ; Markle, Janet ; Okada, Satoshi ; Boisson-Dupuis, Stéphanie ; Casanova, Jean Laurent ; Bustamante, Jacinta. / Mendelian susceptibility to mycobacterial disease : 2014–2018 update. In: Immunology and Cell Biology. 2018.
@article{b6881d9571ec458da1135dc50446e722,
title = "Mendelian susceptibility to mycobacterial disease: 2014–2018 update",
abstract = "Mendelian susceptibility to mycobacterial disease (MSMD) is caused by inborn errors of IFN-γ immunity. Since 1996, disease-causing mutations have been found in 11 genes, which, through allelic heterogeneity, underlie 21 different genetic disorders. We briefly review here progress in the study of molecular, cellular and clinical aspects of MSMD since the last comprehensive review published in 2014. Highlights include the discoveries of (1) a new genetic etiology, autosomal recessive signal peptide peptidase-like 2 A deficiency, (2) TYK2-deficient patients with a clinical phenotype of MSMD, (3) an allelic form of partial recessive IFN-γR2 deficiency, and (4) two forms of syndromic MSMD: RORγ/RORγT and JAK1 deficiencies. These recent findings illustrate how genetic and immunological studies of MSMD can shed a unique light onto the mechanisms of protective immunity to mycobacteria in humans.",
keywords = "IFN-γ, mycobacterium, next-generation sequencing, primary immunodeficiency",
author = "J{\'e}r{\'e}mie Rosain and Kong, {Xiao Fei} and Ruben Martinez-Barricarte and Carmen Oleaga-Quintas and No{\'e} Ramirez-Alejo and Janet Markle and Satoshi Okada and St{\'e}phanie Boisson-Dupuis and Casanova, {Jean Laurent} and Jacinta Bustamante",
year = "2018",
month = "1",
day = "1",
doi = "10.1111/imcb.12210",
language = "English (US)",
journal = "Immunology and Cell Biology",
issn = "0818-9641",
publisher = "Nature Publishing Group",

}

TY - JOUR

T1 - Mendelian susceptibility to mycobacterial disease

T2 - 2014–2018 update

AU - Rosain, Jérémie

AU - Kong, Xiao Fei

AU - Martinez-Barricarte, Ruben

AU - Oleaga-Quintas, Carmen

AU - Ramirez-Alejo, Noé

AU - Markle, Janet

AU - Okada, Satoshi

AU - Boisson-Dupuis, Stéphanie

AU - Casanova, Jean Laurent

AU - Bustamante, Jacinta

PY - 2018/1/1

Y1 - 2018/1/1

N2 - Mendelian susceptibility to mycobacterial disease (MSMD) is caused by inborn errors of IFN-γ immunity. Since 1996, disease-causing mutations have been found in 11 genes, which, through allelic heterogeneity, underlie 21 different genetic disorders. We briefly review here progress in the study of molecular, cellular and clinical aspects of MSMD since the last comprehensive review published in 2014. Highlights include the discoveries of (1) a new genetic etiology, autosomal recessive signal peptide peptidase-like 2 A deficiency, (2) TYK2-deficient patients with a clinical phenotype of MSMD, (3) an allelic form of partial recessive IFN-γR2 deficiency, and (4) two forms of syndromic MSMD: RORγ/RORγT and JAK1 deficiencies. These recent findings illustrate how genetic and immunological studies of MSMD can shed a unique light onto the mechanisms of protective immunity to mycobacteria in humans.

AB - Mendelian susceptibility to mycobacterial disease (MSMD) is caused by inborn errors of IFN-γ immunity. Since 1996, disease-causing mutations have been found in 11 genes, which, through allelic heterogeneity, underlie 21 different genetic disorders. We briefly review here progress in the study of molecular, cellular and clinical aspects of MSMD since the last comprehensive review published in 2014. Highlights include the discoveries of (1) a new genetic etiology, autosomal recessive signal peptide peptidase-like 2 A deficiency, (2) TYK2-deficient patients with a clinical phenotype of MSMD, (3) an allelic form of partial recessive IFN-γR2 deficiency, and (4) two forms of syndromic MSMD: RORγ/RORγT and JAK1 deficiencies. These recent findings illustrate how genetic and immunological studies of MSMD can shed a unique light onto the mechanisms of protective immunity to mycobacteria in humans.

KW - IFN-γ

KW - mycobacterium

KW - next-generation sequencing

KW - primary immunodeficiency

UR - http://www.scopus.com/inward/record.url?scp=85055711153&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85055711153&partnerID=8YFLogxK

U2 - 10.1111/imcb.12210

DO - 10.1111/imcb.12210

M3 - Article

C2 - 30264912

AN - SCOPUS:85055711153

JO - Immunology and Cell Biology

JF - Immunology and Cell Biology

SN - 0818-9641

ER -